🇺🇸 FDA
Patent

US 6844320

Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor

expired A61KA61K31/04A61K31/195

Quick answer

US patent 6844320 (Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor) held by The Board of Regents of the University of Texas System expires Mon Jan 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/04, A61K31/195, A61K31/198, A61K31/295